Sleep Aids - D-A-CH

  • D-A-CH
  • Revenue in the Sleep Aids market amounts to US$0.48bn in 2024. The market is expected to grow annually by 4.21% (CAGR 2024-2029).
  • In global comparison, most revenue is generated in the United States (US$2,103m in 2024).
  • In relation to total population figures, per person revenues of US$4.79 are generated in 2024.

Key regions: Thailand, Indonesia, United States, Europe, Philippines

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids market in D-A-CH, consisting of Germany, Austria, and Switzerland, is experiencing steady growth due to several factors.

Customer preferences:
Customers in the D-A-CH region are increasingly seeking sleep aids to address sleep-related issues such as insomnia and sleep apnea. The high prevalence of these sleep disorders has led to a growing demand for products that can help improve sleep quality. Additionally, the aging population in the region has contributed to the increased need for sleep aids, as older individuals often experience more sleep disturbances.

Trends in the market:
One major trend in the Sleep Aids market in D-A-CH is the rising popularity of natural and herbal sleep aids. Consumers are becoming more conscious of the potential side effects of pharmaceutical sleep aids and are seeking alternative options. This has led to an increase in the demand for products containing natural ingredients such as melatonin, valerian root, and chamomile. Companies are responding to this trend by introducing new products that cater to the growing demand for natural sleep aids. Another trend in the market is the growing availability of sleep aids through online channels. E-commerce platforms have made it easier for consumers to access a wide range of sleep aids, compare prices, and read reviews before making a purchase. This convenience factor has contributed to the growth of online sales in the Sleep Aids market in D-A-CH.

Local special circumstances:
In Germany, the Sleep Aids market is driven by a combination of factors such as a high prevalence of sleep disorders, increasing awareness about the importance of sleep, and a strong healthcare system. The country has a well-established pharmaceutical industry, which has led to the availability of a wide range of sleep aid products. In Austria, the Sleep Aids market is influenced by the country's aging population and the high prevalence of sleep disorders. The government has implemented policies to promote healthy sleep habits and raise awareness about sleep disorders, which has further contributed to the growth of the market. In Switzerland, the Sleep Aids market is driven by a combination of factors such as a high standard of living, a strong healthcare system, and a growing aging population. The country has a well-developed pharmaceutical industry and a high level of consumer awareness about sleep disorders, which has led to a significant demand for sleep aids.

Underlying macroeconomic factors:
The Sleep Aids market in D-A-CH is also influenced by macroeconomic factors such as GDP growth, disposable income levels, and healthcare expenditure. As the economy grows and disposable incomes increase, consumers are more likely to spend on sleep aids to improve their quality of life. Additionally, the healthcare expenditure in the region plays a role in the availability and accessibility of sleep aid products. In conclusion, the Sleep Aids market in D-A-CH is experiencing growth due to customer preferences for natural sleep aids, the availability of products through online channels, and local special circumstances such as the high prevalence of sleep disorders and the aging population. The underlying macroeconomic factors, including GDP growth and healthcare expenditure, also contribute to the development of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)